What we do
Testing, laboratory support and community response to COVID-19 in Nigeria.
IHVN provides COVID-19 services in Nasarawa, Federal Capital Territory, Rivers, and Kastina states through high-level collaboration with the national and state primary health care development agencies. We provide technical support at the national and sub-national levels – Technical Working Groups, and the vaccinating teams in line with the SCALES strategy of the Federal Government of Nigeria. We were able to support the FGoN to vaccinate over 2M Nigerians (an achievement of our program).
Strategies deployed to support the Federal Government to vaccinate more than 2 million Nigerians include:
With Program Integration (PI) we are linking the people living with HIV (PLHIV) to comprehensive healthcare through integrated patient-centred approaches, this will enhance the quality of life of PLHIVs. PLHIVs can now receive care for HIV/COVID-19/Non-Communicable Diseases/Tuberculosis in the same clinic.
In-patient Treatment with Anti-Coronavirus Immunoglobulin
(ITAC) study is an international multi-center trial of the safety, tolerability and efficacy of anti-coronavirus hyper-immune intravenous immunoglobulin (hIVIG) for the treatment of adult hospitalized patients at the…
Research · COVID-19 response
Nasarawa State SURGE Project
Nasarawa SURGE project commenced in May 2019 in response to the Nigeria HIV/AIDS Impact and Indicator Survey (NAIIS) . The survey placed HIV prevalence rate at 2.0% with an estimated 23,306 people living with HIV…
HIV · COVID-19 response
Strategies and Treatments for Respiratory Infections & Viral Emergencies
The Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) project is a randomized, placebo-controlled clinical trial seeking to evaluate the clinical efficacy of the antiviral drug Ensitrelvir…
Research · COVID-19 response
Therapeutics for Inpatients with COVID-19 (TICO) Study
The Therapeutics for Inpatients with COVID-19 (TICO) study is a follow up on the In-patient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) study, which was also implemented by the Institute of Human Virology…
Research · COVID-19 response
Vaccination for Recovered In-patients with COVID-19 (VATICO Study)
The Vaccination for Recovered In-patients with COVID-19 (VATICO) study is a phase 4 open-label trial which will be Investigating the difference in antibody level to mRNA (Moderna or the Pfizer BioNTech) in study…
Research · COVID-19 response
The International Research Centre of Excellence (IRCE) at the Institute of Human Virology Nigeria (IHVN) has hosted its 3rd Annual Scientific Symposium, convening leading health experts, policymakers, and development partners from across Nigeria and abroad to discuss strategies…
To discuss opportunities to strengthen the use of data on Adverse Events Following Immunisation (AEFI) surveillance, the International Research Center of Excellence (IRCE) at Institute of Human Virology Nigeria (IHVN) has organized a meeting for stakeholders in Abuja.
The International Research Center of Excellence (IRCE) at the Institute of Human Virology Nigeria (IHVN) has partnered with The Young Missionary Movement (YOMM) of Nigeria to launch an initiative to equip young people from the 36 states of Nigeria with vital data science skills…
